Vaxxinity (NASDAQ:VAXX) Lowered to Hold at Zacks Investment Research

Vaxxinity (NASDAQ:VAXX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ […]

Related Keywords

United States ,Dallas ,Texas , ,Geode Capital Management ,Goldman Sachs Group Inc ,Zacks Investment Research ,Investment Advisers ,United Biomedical Inc ,Vaxxinity Company Profile Get Rating ,Managers Group ,Vaxxinity Inc ,Get Rating ,Capital Management ,Sachs Group ,Adage Capital Partners ,Company Profile ,Lewy Body ,Vaxxinity ,Nasdaq Vaxx ,Vaxx ,Medical ,Downgrade ,